JURIST - Paper Chase: New Jersey verdict for Vioxx drugmaker upheld

[JURIST] A New Jersey superior court judge Monday upheld a Friday jury verdict [DowJones report] for Merck & Co [corporate website], finding that the company had given adequate warning to physicians of the risks associated with its painkiller Vioxx [FDA backgrounder; JURIST news archive]. Judge Carol Higbee rejected a motion by plaintiffs attorney Mark Lanier disputing a finding that the drug company had warned doctors prescribing Vioxx that a 2004 study showed the drug doubled the risk of heart attack or stroke in patients who took it for longer than 18 months; Lanier represents the estate of a deceased man whose fatal heart attack is alleged to have been caused by the drug.

Merck faces more than 27,000 lawsuits from people who say they were harmed by the once $2.5 billion-a-year drug before it was pulled from the market [press release] in September of 2004. Merck has set aside $1 billion to fight every Vioxx court challenge. In November 2006, a federal judge declined to certify a national class action suit [JURIST report], ruling that it made more sense to try the cases in their respective states of origin. Reuters has more.

For a one-stop snapshot of the latest legal news that matters, with breaking documents, new legal videos, live law-related webcasts, commentary by expert law professors and more - all updated through the day in real time, with no ads and no registration barriers - visit JURIST's homepage and check back often...